FLURAZEPAM 30MG CAPSULE
FLURAZEPAM 30MG CAPSULE
Discontinued
DIN Number
02232657
Drug Class
Human
Market Date
N/A
Company
HC
Laboratoires Confab Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02232657
AIG Number0108704001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD01 FLURAZEPAM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLURAZEPAM HYDROCHLORIDEActive
Strength: 30 MG / CAP
Monograph: FLURAZEPAM HYDROCHLORIDE